Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Rewriting the Treatment Script in CLL: Guidance on Integrating Modern Targeted and Next-Gen Options Into Patient Care

This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.

Live and Virtual Symposium at ASCO 2022

Friday, June 3, 2022 at 7:00-8:30 PM CDT / 8:00-9:30 PM EDT

Join CLL Society and PeerView Institute to learn updates on the latest CLL data from a panel of experts including Drs. Anthony Mato, Nicole Lamanna, Matthew Davids, and Catherine Coombs and gain their insight into the practicalities of therapeutic planning, including safety considerations associated with BTKi, PI3Ki, BCL-2i, and CAR-T therapy. This Masterclass and Case Forum will include topics such as personalized, evidence-based selection of upfront treatment strategies; therapeutic planning based on safety considerations; collaborative management of adverse events; treatment sequencing in relapsed/refractory CLL; and preparing for novel combinatorial and cellular therapy strategies.

The symposium is geared towards healthcare professionals, but all are welcome to attend and learn. Registration is free and a short survey is included.